Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Zhi, Kangkang ^a   Shen, Xiaojun ^a   Zhang, Hao ^a   Bi, Jianwei ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FIBROBLAST ACTIVATION PROTEIN; SEPRASE; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ACTIN; CALCIUM BINDING PROTEIN; COLLAGEN TYPE 1; FSP1 PROTEIN, HUMAN; MESSENGER RNA;

ADULT; ARTICLE; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; ADOLESCENT; AGED; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; GENETICS; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PERITONEUM TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; SURVIVAL RATE;

ACTINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; COLLAGEN TYPE I; FEMALE; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 77953126275     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-66     Document Type: Article

References (39)

1. Molecular markers for gastric adenocarcinoma: an update. C Anderson A Nijagal J Kim, Mol Diagn Ther 2006 10 345 352 17154651
2. Sabiston Textbook of Surgery. CM Townsend Jr RD Beauchamp BM Evers KL Mattox, Saunders, An Imprinter of Elsevier. Philadelphia 18 2008
3. Clinicopathological characteristics and predictive markers of early gastric cancer with recurrence. JW Kim I Hwang MJ Kim SJ Jang, J Korean Med Sci 2009 24 1158 1164 10.3346/jkms.2009.24.6.1158 19949675
4. Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years. R Miyahara Y Niwa T Matsuura O Maeda T Ando N Ohmiya A Itoh Y Hirooka H Goto, J Gastroenterol Hepatol 2007 22 1435 1442 10.1111/j.1440-1746.2007.04991.x 17573829
5. Classification of lymphnode metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. P Aurello F D'Angelo S Rossi R Bellagamba C Cicchini G Nigri G Ercolani R De Angelis G Ramacciato, Am Surg 2007 73 359 366 17439029
6. Fibroblasts in cancer. R Kalluri M Zeisberg, Nat Rev Cancer 2006 6 392 401 10.1038/nrc1877 16572188
7. Friends or foes - bipolar effects of the tumour stroma in cancer. MM Mueller NE Fusenig, Nat Rev Cancer 2004 4 839 849 10.1038/nrc1477 15516957
8. Stromal fibroblasts in cancer initiation and progression. NA Bhowmick EG Neilson HL Moses, Nature 2004 432 332 337 10.1038/nature03096 15549095
9. Tumor stroma and regulation of cancer development. TD Tlsty LM Coussens, Annu Rev Pathol 2006 1 119 150 10.1146/annurev.pathol.1.110304.100224 18039110
10. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. W Qiu M Hu A Sridhar K Opeskin S Fox M Shipitsin M Trivett ER Thompson M Ramakrishna KL Gorringe K Polyak I Haviv IG Campbell, Nat Genet 2008 40 650 655 10.1038/ng.117 18408720
11. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. G Ayala JA Tuxhorn TM Wheeler A Frolov PT Scardino M Ohori M Wheeler J Spitler DR Rowley, Clin Cancer Res 2003 9 4792 4801 14581350
12. No Association of Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-C Expression with Survival in Patients with Gastric Cancer. SJ Lee JG Kim SK Sohn YS Chae JH Moon SN Kim HI Bae HY Chung W Yu, Cancer Res Treat 2009 41 218 223 10.4143/crt.2009.41.4.218 20057967
13. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. AF Olumi GD Grossfeld SW Hayward PR Carroll TD Tlsty GR Cunha, Cancer Res 1999 59 5002 5011 10519415
14. Putting tumours in context. MJ Bissell D Radisky, Nat Rev Cancer 2001 1 46 54 10.1038/35094059 11900251
15. Co-evolution of tumor cells and their microenvironment. K Polyak I Haviv IG Campbell, Trends Genet 2009 25 30 38 10.1016/j.tig.2008.10.012 19054589
16. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. SW Hayward Y Wang M Cao YK Hom B Zhang GD Grossfeld D Sudilovsky GR Cunha, Cancer Res 2001 61 8135 8142 11719442
17. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. N Cheng NA Bhowmick A Chytil AE Gorksa KA Brown R Muraoka CL Arteaga EG Neilson SW Hayward HL Moses, Oncogene 2005 24 5053 5068 10.1038/sj.onc.1208685 15856015
18. Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis. N Cheng A Chytil Y Shyr A Joly HL Moses, Cancer Res 2007 67 4869 4877 10.1158/0008-5472.CAN-06-3381 17495323
19. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. A Noel MC De Pauw-Gillet G Purnell B Nusgens CM Lapiere JM Foidart, Br J Cancer 1993 68 909 915 8217606
20. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. X Guo H Oshima T Kitmura MM Taketo M Oshima, J Biol Chem 2008 283 19864 19871 10.1074/jbc.M800798200 18495668
21. Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. G Gabbiani Y Kapanci P Barazzone WW Franke, Am J Pathol 1981 104 206 216 6170230
22. Identification and characterization of a fibroblast marker: FSP1. F Strutz H Okada CW Lo T Danoff RL Carone JE Tomaszewski EG Neilson, J Cell Biol 1995 130 393 405 10.1083/jcb.130.2.393 7615639
23. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. M Iwano A Fischer H Okada D Plieth C Xue TM Danoff EG Neilson, Mol Ther 2001 3 149 159 10.1006/mthe.2000.0251 11237671
24. Effect of fibroblast activation protein and [alpha]2-antiplasmin cleaving enzyme on collagen types I, III, and IV. VJ Christiansen KW Jackson KN Lee PA McKee, Arch Biochem Biophys 2007 457 177 186 10.1016/j.abb.2006.11.006 17174263
25. Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. S Aggarwal WN Brennen TP Kole E Schneider O Topaloglu M Yates RJ Cotter SR Denmeade, Biochemistry 2008 47 1076 1086 10.1021/bi701921b 18095711
26. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. SJ Cohen RK Alpaugh I Palazzo NJ Meropol A Rogatko Z Xu JP Hoffman LM Weiner JD Cheng, Pancreas 2008 37 154 158 10.1097/MPA. 0b013e31816618ce 18665076
27. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. P Garin-Chesa LJ Old WJ Rettig, PNAS 1990 87 7235 7239 10.1073/pnas.87.18.7235 2402505
28. FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions. MA Goscinski Z Suo VA Flørenes L Vlatkovic JM Nesland KE Giercksky, Ultrastruct Pathol 2008 32 89 96 10.1080/ 01913120802034934 18570153
29. Clinical implications of fibroblast activation protein in patients with colon cancer. LR Henry HO Lee JS Lee A Klein-Szanto P Watts EA Ross WT Chen JD Cheng, Clin Cancer Res 2007 13 1736 1741 10.1158/1078-0432.CCR-06-1746 17363526
30. Molecular cloning of fibroblast activation protein a, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. MJ Scanlan BK Raj B Calvo P Garin-Chesa MP Sanz-Moncasi JH Healey LJ Old WJ Rettig, PNAS 1994 91 5657 5661 10.1073/pnas.91.12.5657 7911242
31. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. AM Santos J Jung N Aziz JL Kissil E Puré J Clin Invest 2009 119 3613 3625 19920354
32. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. A Orimo PB Gupta DC Sgroi F Arenzana-Seisdedos T Delaunay R Naeem VJ Carey AL Richardson RA Weinberg, Cell 2005 121 335 348 10.1016/j.cell.2005.02.034 15882617
33. Crosstalk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. M Ao OE Franco D Park D Raman K Williams SW Hayward, Cancer Res 2007 67 4244 4253 10.1158/0008-5472. CAN-06-3946 17483336
34. Emerging roles of chemokines in prostate cancer. D Vindrieux P Escobar G Lazennec, Endocr Relat Cancer 2009 16 663 673 10.1677/ERC-09-0109 19556286
35. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. JA Tuxhorn SJ McAlhany F Yang TD Dang DR Rowley, Cancer Res 2002 62 6021 6025 12414622
36. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. M Shimoda KT Mellody A Orimo, Semin Cell Dev Biol 2010 21 19 25 10.1016/j.semcdb.2009.10.002 19857592
37. Matrix metalloproteases as molecular markers in gastric cancer. S de la Pẽa C L Sampieri K Leán-Cárdoba, Med Clin (Barc) 2010 134 123 126 10.1016/j.medcli.2009.09.031 19944435
38. Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer. J Ge Z Chen S Wu J Chen X Li J Li J Yin Z Chen, Digestion 2009 80 148 158 10.1159/000226089 19713703
39. Lymphangiogenesis in gastric carcinoma correlates with prognosis. P Gao GY Zhou QH Zhang ZX Su TG Zhang L Xiang Y Wang SL Zhang K Mu, J Pathol 2009 218 192 200 10.1002/path.2523 19224540